semaglutide $200 a month Ozempic and Wegovy weight loss drugs are life changers, for those who can afford them

The FDA is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday

26.04

★★★★☆4.8 (126)

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many

29.35

★★★★★4.9 (98)

Americans turn to risky unregulated sellers for GLP-1 weight-loss drugs

25.10

★★★★★5.0 (157)

National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and

22.90

★★★★★4.7 (84)

FEDS CRACKDOWN: The I-Team has learned the feds are cracking down on unapproved versions of GLP-1s sold online. The FDA says these are not approved or tested by the FDA. The I-Team found many people

21.89

★★★★★4.9 (203)

The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and

26.54

★★★★★5.0 (176)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

29.66

★★★★★4.8 (132)